Ex-Texas US Rep. Blake Farenthold, who left office amid harassment allegations, dies at 63
Former Texas Republican U.S. Rep. Blake Farenthold , who left Congress amid sexual harassment allegations, has died. He was 63.
He died in a Corpus Christi hospital and suffered heart and liver problems in recent years, Steve Ray, his former longtime political consultant, said. Farenthold's wife, Debbie Farenthold, confirmed that he died Friday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes
Common obesity drug reduced the risk of disease progression by 54% CHICAGO, June 21, 2025 /PRNewswire/ -- Today, a new analysis demonstrates the vascular benefits of semaglutide in patients with peripheral artery disease (PAD) and type 2 diabetes, including improvement in symptoms, quality of life, and disease progression in patients. An analysis of the STRIDE trial was presented as a late-breaking symposium at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago and simultaneously published in Diabetes Care®. PAD is a serious condition impacting 230 million individuals globally and up to 30% of people with diabetes. PAD narrows arteries and reduces blood flow to the legs, causing marked disability, affecting quality of life, and putting people at increased risk of severe complications including amputations and death. Treatment options are currently limited, and little advancements in PAD treatment have occurred for more than 25 years. The STRIDE trial is a phase 3, multinational, double-blind, randomized clinical trial conducted at 112 outpatient clinical trial sites in 20 countries in North America, Asia, and Europe. 792 patients aged 18 years and older with type 2 diabetes and PAD with intermittent claudication (a symptom of PAD that causes muscle pain or cramping in the legs during physical activity) and reduced ankle-brachial or toe-brachial index (indicators of restricted blood flow to the legs), were randomly assigned to receive either semaglutide (n=396) or placebo (n=396) over a 52-week period to assess the impact on walking capacity, symptoms, and quality of life. The median age was 68 years, and 195 (25%) participants were female and 597 (75%) were male. The sub-analysis builds on results previously published in The Lancet, demonstrating that semaglutide significantly improved walking outcomes in people with PAD and diabetes, enhanced quality of life, and reduced the risk of disease progression by 54%. At week 52, the estimated median ratio to baseline in maximum walking distance was 1.21 in the semaglutide group compared to 1.08 in the placebo group. Semaglutide was well tolerated, with no treatment-related deaths and a low rate of serious adverse events (1%), consistent with its known safety profile. The analyses from STRIDE presented new and critical information on the benefits of semaglutide, which were observed independent of baseline levels of A1C, duration of diabetes, or intensity of diabetes. Furthermore, the benefits were seen across all BMI categories and regardless of the treatment with SGLT2 inhibitors. "These findings indicate that clinicians can now recognize semaglutide as a vascular protective medication, with benefits that extend beyond lowering weight or A1C," said Professor Subodh Verma, MD, PhD, FRCSC, FAHA, FCAHS, cardiovascular surgeon, University of Toronto, Toronto, Canada, and senior author of the STRIDE trial. "The totality of data now suggest that in people with diabetes, semaglutide favorably affects the pipes [atherosclerosis], pump [heart failure], filter [kidney outcomes]. And, in patients with PAD, these new data provide robust evidence that semaglutide is a therapy to improve their function, quality of life, and progression of disease."The study authors indicate that further research is warranted to understand whether these benefits extend to individuals with PAD who do not have diabetes. Research presentation details:Dr. Verma will present the findings at the following symposium: Symposium: Diabetes and Peripheral Artery Disease—Evolving Role of GLP-1 RA and New Insights from the STRIDE Trial Presented on Saturday, June 21 at 1:30 p.m. CT About the ADA's Scientific SessionsThe ADA's 85th Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in Chicago, IL, on June 20–23. Thousands of leading physicians, scientists, and health care professionals from around the world are expected to convene both in person and virtually to unveil cutting-edge research, treatment recommendations, and advances toward a cure for diabetes. Attendees will receive exclusive access to thousands of original research presentations and take part in provocative and engaging exchanges with leading diabetes experts. Join the Scientific Sessions conversation on social media using #ADASciSessions. About the American Diabetes AssociationThe American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure—and we're not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn). Media Contact: Mimi Carmody, MCarmody@ View original content to download multimedia: SOURCE American Diabetes Association Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
Health care workers on alert for ICE raids in hospitals
President Trump's whittling away of protected places for immigrants has fueled fears among health care workers that Immigration and Customs Enforcement (ICE) agents will arrest patients in or around hospitals. In January, the Trump administration rescinded a Biden-era policy that protected certain areas like churches, schools and hospitals from immigration enforcement. And lawmakers in at least one state have introduced legislation aimed at making it easier for ICE to make arrests in hospitals. As the Department of Homeland Security (DHS) seeks to ramp up ICE raids at hotels, restaurants, farms and other sites, nurses worry their workplace could be next. 'We were all worried about what this meant,' Michael Kennedy, a nurse at a University of California, San Diego health facility located very near the U.S.-Mexico border, said of the policy changes under Trump. 'As we've seen these immigration raids ramp up, our first thought is about our patients and what that means for them.' ICE agents made a record number of migrant arrests in a single day this month and have appeared outside of courthouses in Seattle and stores in the New York City area. The agency's workplace raids in Los Angeles spurred days of protests, which in turn prompted a heavy-handed response from the Trump administration. Sandy Reding is a nurse at a hospital in Bakersfield, Calif., which serves communities of farm workers and employs a diverse staff. 'There is a lot of concern [about] ICE agents showing up with FBI or with the military, because we've seen a lot of reports on TV, and we have reports in our area where this is happening as well,' she said. Reding and her fellow nurses, she said, are also worried that the news of increased ICE raids will deter some patients from coming to the hospital to seek care. 'What we are going to see is a large burden on communities and hospitals if people delay care,' Reding said. 'And there are worse outcomes.' Nancy Hagan, an intensive care unit nurse at Maimonides Medical Center in New York City, said those concerns have come to fruition at her hospital. In May, she said, an immigrant New Yorker had appendicitis but waited too long to go to the emergency room. Their appendix burst, spreading infected tissue and bacteria to other organs, which ultimately killed them. 'Once patients hear that a hospital is no longer a safe place for them to go, they are afraid to come to the hospital,' she said. Hagan, a Haitian immigrant, added that she and her colleagues, who work at hospitals across the city, have noticed that emergency rooms appear to be emptier in recent months. Kennedy, the nurse in San Diego, said the Level 1 trauma center, which is typically packed, has been emptier than usual. He admitted the decline in patient visits could be seasonally related, but he said he believes that the possibility of ICE agents arresting immigrants is having a 'chilling effect.' 'I can't see how this doesn't affect our patients' willingness to seek care,' he said. 'I'm willing to bet that a lot of people are delaying care because they're afraid.' ICE did not get back to The Hill in response to questions on whether agents have arrested people in or around hospitals, or if there are plans to do so. DHS announced in January that it had rescinded former President Biden's guidelines on immigration enforcement at 'sensitive locations' that were first issued under former President Obama. 'The Trump Administration will not tie the hands of our brave law enforcement, and instead trusts them to use common sense,' a DHS spokesperson said at the time. The National Immigration Law Center said that while immigrants no longer have special protections at hospitals and other 'sensitive locations,' they still have basic rights. 'Instead, individuals will need to rely on basic constitutional protections in these spaces,' it said in a fact sheet. 'Specifically, the Fourth Amendment protects all individuals from unreasonable searches and seizures, and the Fifth Amendment ensures the right to remain silent when confronted by law enforcement.' The Emergency Medicine Residents' Association has distributed a flyer with step-by-step guidance for health care workers on dealing with ICE agents if they do enter hospitals. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Associated Press
28 minutes ago
- Associated Press
American Heart Association mourns the passing of former chief executive Cass Wheeler
( NewMediaWire ) - June 21, 2025 - Dallas, TX — The American Heart Association is deeply saddened to announce the passing of its former Chief Executive Officer, Cass Wheeler, who led the Association professional staff for more than three decades with extraordinary commitment and compassion. Wheeler, a long-time Georgetown, Texas resident, passed away peacefully following a neurodegenerative illness. He was 84. Cass Wheeler served as CEO of the American Heart Association, a global force changing the future of health for all, from 1998 until his retirement in 2008, capping a 35-year tenure with the organization. His leadership marked a transformational era for the Heart Association, guiding the nonprofit into the 21st century and dramatically expanding its global influence in public health, cardiovascular science, fundraising and community engagement. 'Cass Wheeler was more than a leader — he was a mentor, a dear friend, and a relentless champion for every person at risk of cardiovascular disease,' said Nancy Brown, CEO of the American Heart Association. 'He believed deeply in the power of purpose, and he inspired generations of staff and volunteers to push beyond boundaries. I would not be where I am today without his guidance and belief in me. His legacy lives in the millions of lives touched by the work he helped build.' Among his many accomplishments, Wheeler completed the organizational consolidation of individual state and metropolitan affiliates into 15 streamlined geographic operating affiliates, adopting a more contemporary and efficient, unified corporate structure that enhanced the Association's effectiveness and impact. Under Wheeler's leadership, the Association launched the groundbreaking 'Go Red for Women(TM)' campaign, raising worldwide awareness of the impact of heart disease on women and began the American Stroke Association, a division started in 1998 dedicated to reducing disability and death from stroke. He also led the charge to develop the Get With The Guidelines(R) initiative to improve the overall quality of cardiovascular care in hospitals, the Alliance for a Healthier Generation in partnership with the William J. Clinton Foundation to combat childhood obesity, and the Association's school-based programs teaching children the importance of heart health and philanthropy -- all initiatives that continue to this day as cornerstones of the Association's community impact. He also personally played a pivotal role in expanding research funding, strengthening stroke awareness, and advancing access to healthcare for everyone, everywhere, long before the topic became a national conversation. Wheeler was instrumental in sharpening the Association's focus on public policy and advocacy, in the process helping secure landmark public health legislation across the country — including stronger tobacco control laws and improved nutrition labeling. A native Texan, he graduated from the University of Texas at Austin with a business degree. Immediately after graduation, he joined the American Cancer Society, gaining valuable non-profit healthcare experience. He then transitioned into finance, working as a stockbroker in Dallas for two New York Stock Exchange firms. Wheeler joined what was then the Texas Affiliate of American Heart Association in 1973 and steadily rose through the staff ranks. Known for his humility and hands-on leadership style, he always put mission and people first. After retiring, he remained active as a speaker, consultant and author, sharing lessons from his career in his book You've Got to Have Heart: Achieving Purpose Beyond Profit in the Social Sector. Despite recent health challenges, Wheeler remained deeply engaged with Association leadership. One year ago, he helped ring in the Association's centennial in Chicago, sharing his legacy and leadership. Wheeler was a leader on many nonprofit boards and commissions during his tenure with the Heart Association. He was the co-convener of the Panel on the Nonprofit Sector, formed by the Senate Finance Committee to enhance governance in charities, a member of the Commission on Improving Economic Opportunity in Communities Dependent on Tobacco Production appointed by then President William B. Clinton, and served on boards of National Human Services Assembly, Partnership for Prevention, Campaign for Tobacco-Free Kids, Research!America, National Health Council, American Legacy Foundation, National Council on Aging, Better Business Bureau's Wise Giving Alliance, and more. He was also an active consultant and university guest lecturer following his professional career. He is survived by his children Kevin Wheeler, Kristen Wheeler, grandchildren Trinity Wheeler, Cash Wheeler, stepchildren Austin Schonfeld and Chloe Schonfeld, and a wide circle of colleagues and friends who cherished his integrity, warmth and wisdom. A memorial service is being planned, and details will be shared by the family in the coming days. In lieu of flowers, the family requests donations be made to the American Heart Association in honor of Cass Wheeler's lifelong dedication to building health and hope, for everyone everywhere. VIDEO: Visionary leader Cass Wheeler leaves enduring legacy in the fight against heart disease and stroke. ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. The organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: American Heart Association: Greg Donaldson; [email protected] For Public Inquiries: 1-800-AHA-USA1 (242-8721) and
